Learn about MCAS and eating disorders at our event

Join Dr Andreea Ciudin to learn how obesity medications can be tailored to support management of specific obesity-related complications. Drawing on the latest evidence from the EASO Pharmacological Treatment Algorithm, she highlights practical guidance for managing obesity alongside conditions including type 2 diabetes, cardiovascular diseases, liver disease, sleep apnoea, and osteoarthritis. https://lnkd.in/eATYhz3g

Eating behavior assessment for obesity: a reliable tool for detecting binge eating disorder in patients with obesity Authors Elvira Anna Carbone, Marianna Rania, Daria Quirino, Lavinia Rotella, Paola Carosi, Alessandra Siniscalchi, Matteo Aloi, Cristina Segura-Garcia Volume 1, Issue 2, July 2025 Open access paper 👉 https://lnkd.in/eiZ4_a6e Significance Binge eating disorder (BED) is often overlooked in individuals with obesity, worsening clinical and treatment outcomes. This study validates the Eating Behaviors Assessment for Obesity (EBA-O) as an effective tool for detecting BED, with high accuracy (AUC = 0.89), sensitivity (81%), and specificity (82%). While not a substitute for clinical diagnosis, the EBA-O offers a practical tool for early BED detection, improving obesity management. Volume 1, Issue 2, July 2025 Open access paper 👉 https://lnkd.in/eiZ4_a6e #endocrinology #obesity

➡️ There are several conditions, including various functional gastrointestinal disorders, that can have a similar clinical presentation to gastroparesis and are associated with delays in gastric emptying. 🔗 Read this 'Mistakes in...' article by Asma Fikree on Gutlix: https://bit.ly/47sHl7J

Luteolin is gaining recognition in neuroscience research! This flavonoid's ability to cross the blood-brain barrier and modulate neuroinflammation makes it promising for cognitive support. The olive oil formulation enhances bioavailability significantly compared to standard extracts. Smart approach addressing phenol sensitivity while maximizing absorption.

🩺 Acid-Base Disorders Simplified 1️⃣ Respiratory Acidosis • What: Blood too acidic due to CO₂ retention. • Causes: COPD, asthma, drug overdose, respiratory muscle weakness. • Labs: ↑ PaCO₂, ↓ pH • Compensation: Kidneys retain bicarbonate (HCO₃⁻) 2️⃣ Respiratory Alkalosis • What: Blood too alkaline due to excessive CO₂ loss. • Causes: Hyperventilation from anxiety, pain, fever, hypoxia. • Labs: ↓ PaCO₂, ↑ pH • Compensation: Kidneys excrete bicarbonate 3️⃣ Metabolic Acidosis • What: Blood too acidic due to acid gain or bicarbonate loss. • Causes: Diabetic ketoacidosis, lactic acidosis, renal failure, diarrhea. • Labs: ↓ HCO₃⁻, ↓ pH • Compensation: Lungs blow off CO₂ (fast breathing) 4️⃣ Metabolic Alkalosis • What: Blood too alkaline due to acid loss or bicarbonate gain. • Causes: Vomiting, nasogastric suction, excessive antacids. • Labs: ↑ HCO₃⁻, ↑ pH • Compensation: Lungs retain CO₂ (slow breathing) 💡 Tip: Respiratory disorders → lungs first, kidneys compensate. Metabolic disorders → kidneys first, lungs compensate. #MedicalEducation #NursingStudents #HealthcareProfessionals #ClinicalKnowledge #MedicalLearning #AcidBaseBalance #NursingCare #HealthAwareness #MedicalConcepts #FutureNurse #StudyWithMe #LearningNeverStops #HealthcareCommunity #MedicalScience #EducationMatters

Many ED clinicians never think about how often digestive disorders show up in their work. But the numbers are striking - over 95% of ED clients experience some form of gut-brain dysfunction. I’ve spent the last 8 years learning, educating, and speaking out about the complex ways these two conditions intersect and why it matters so much for treatment and support. In my recent article “The Complex Ways Eating Disorders and Digestive Disorders Intersect,” I draw from nearly a decade of work to highlight how often these two conditions go hand-in-hand, and why recognizing that connection is essential for effective treatment, compassionate care, and long-term recovery. From understanding IBS to exploring treatment tools beyond food, this article offers both clarity and encouragement. https://buff.ly/Oz3zpQ4 #EDClinicians #EatingDisorders #IBS #DigestiveHealth #EatingDisorderRecovery #IBSAwarenessmonth #MoreThanAStomachache #LifeWithIBS

𝐈𝐧𝐯𝐢𝐬𝐢𝐛𝐥𝐞, 𝐲𝐞𝐭 𝐥𝐢𝐟𝐞-𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠. Inflammatory Bowel Disease (#IBD), affects thousands* in Belgium—quietly, invisibly with a deep impact on their lives. To mark Belgian National IBD Day, we’re launching #RevealingTheInvisible— a three-part video series featuring honest conversations with patients and healthcare professionals about what really matters in IBD care. 🎥 In the first episode of our #RevealingTheInvisible series, patients share what it’s like to live with Crohn’s disease or Colitis Ulcerosa: the uncertainty of tomorrow, the need to constantly adapt, and the reality of an “invisible disability” that’s often misunderstood. We also spoke with gastroenterologists, who emphasize that IBDs should not be seen as “just digestive diseases”. They call for more multidisciplinary care with medical, nutritional, psychological and social support. They explain why investing in this integrated care model is essential, and how it can lead to meaningful improvements in patient outcomes and overall quality of life. 💬 They remind us that true progress in IBD care means addressing every aspect of a patient’s journey: fatigue, daily challenges, mental wellbeing and regaining confidence. Discover what they believe is essential and join us in making the invisible visible. We want to thank the specialists and patients who took part in the video series: Dr. Flamme Frédéric, Prof. Edouard Louis, Dr. Tom Holvoet, Dr. @Elodie De Ruyck, Katleen Franc from Asbl Crohn RCUH and Lynn D. from Crohn en Colitis ulcerosa vereniging vzw #RevealingTheInvisible #IBD #ChronicIllness #BetterCare #Takeda #IBDDay #MICI #Crohn #Colitis *Reference : Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021

Exciting new research from Dr. Andrew Braun and team! Their study in Metabolism shows that the KCa channel activator SKA-31 can improve cardiovascular function in individuals with type 2 diabetes. This work reveals a potential novel strategy to decrease the risk of CV-related morbidity in Type 2 diabetes. Read more: https://lnkd.in/gkVmPt-r ----------------- #UCalgary #UCalgaryMed #LibinInstitute Cumming School of Medicine UCalgary

New from Dr. Carla Miller! 📘 "Goal Integration of Diabetes Self-Management Education and Psychosocial Support With Pharmacotherapy for Weight Loss in Adults With Type 2 Diabetes and Obesity" Read the full study: https://lnkd.in/gwFVGa3n #ResearchExcellence #DiabetesCare #NutritionResearch #HealthInnovation #IndianaUniversity #AppliedHealthScience

New research, evolving technologies, and breakthroughs in prevention are redefining what’s possible in cardiovascular health.   This dynamic session explores emerging opportunities to prevent heart disease and metabolic disorders through innovation in: 💊 High blood pressure management 💓 Lipid control ⚖️ Obesity prevention 📱 Technology and data-driven care   Together, these insights show how we can make a measurable, lasting impact today and for generations to come.   #NationalForum2025 #InnovationInHealth #CardiovascularHealth